Mark J. Carvlin
Private Equity Investor chez Mi3 Venture Partners Management LLC
Postes actifs de Mark J. Carvlin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Mi3 Venture Partners Management LLC
 Mi3 Venture Partners Management LLC Investment ManagersFinance Mi3 Venture Partners Management LLC (MI3 Venture Partners) is a venture capital firm founded in 1999 by William D. McPhee. The firm is headquartered in Wellesley, Massachusetts. | Private Equity Investor | 01/01/2000 | - |
Historique de carrière de Mark J. Carvlin
Anciens postes connus de Mark J. Carvlin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Sales & Marketing | 01/01/1989 | 31/12/1993 |
| Georgetown University | Corporate Officer/Principal | - | - |
Bracco Diagnostics, Inc.
 Bracco Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Bracco Diagnostics, Inc. manufactures chemicals and allied products. It develops and markets diagnostic pharmaceutical products including Isovue X-ray contrast agent, ProHance MRI contrast agent and nuclear medicine products pharmaceuticals in North America. It is a subsidiary of Bracco SPA. The company is headquartered in Princeton, NJ | Corporate Officer/Principal | - | - |
Formation de Mark J. Carvlin
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Private Equity Investor | 1 |
| Sales & Marketing | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
Mi3 Venture Partners Management LLC
Mi3 Venture Partners Management LLC Investment ManagersFinance Mi3 Venture Partners Management LLC (MI3 Venture Partners) is a venture capital firm founded in 1999 by William D. McPhee. The firm is headquartered in Wellesley, Massachusetts. | Finance |
Bracco Diagnostics, Inc.
Bracco Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Bracco Diagnostics, Inc. manufactures chemicals and allied products. It develops and markets diagnostic pharmaceutical products including Isovue X-ray contrast agent, ProHance MRI contrast agent and nuclear medicine products pharmaceuticals in North America. It is a subsidiary of Bracco SPA. The company is headquartered in Princeton, NJ | Health Technology |
- Bourse
- Insiders
- Mark J. Carvlin
- Expérience
